Citigroup
FEED

Citigroup’s ENvue Medical Inc FEED Stock Holding History

Citigroup’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$2 – 6231
2025
Q4 		$2 Hold
1
– – ﹤0.01% 5931
2025
Q3 		$6 Sell
1
-249
-100% -$1.87K ﹤0.01% 5973
2025
Q2 		$2.32K Buy
+250
New +$7.45K ﹤0.01% 5354
2022
Q2 		– Sell
-3
Closed -$7K – 6506
2022
Q1 		$7K Buy
+3
New +$5.66K ﹤0.01% 5692

Other funds holding FEED

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PCM
Poehling Capital Management Madison, Wisconsin $466M AUM 24.17% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citigroup's FEED Position: Q1 2026 in Review

Citigroup sold out of ENvue Medical Inc (FEED) in Q1 2026, closing a stake of 1 share — an estimated $2 sold.

Citigroup first reported a position in FEED in Q1 2022 and held it in 4 quarters. The position peaked at $7K in Q1 2022. 13 funds tracked by Wall St. Rank hold FEED as of Q1 2026.

  • Citigroup reported no remaining ENvue Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 ENvue Medical Inc share in Q1 2026, an estimated $2.
  • Citigroup first reported a position in ENvue Medical Inc in Q1 2022 and held it in 4 quarters.
  • Citigroup's ENvue Medical Inc position peaked at $7K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.